Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors M Harris, T Rhodes Harm reduction journal 10, 1-11, 2013 | 329 | 2013 |
Frequency of health‐care utilization by adults who use illicit drugs: a systematic review and meta‐analysis D Lewer, J Freer, E King, S Larney, L Degenhardt, EJ Tweed, VD Hope, ... Addiction 115 (6), 1011-1023, 2020 | 151 | 2020 |
Methadone diversion as a protective strategy: the harm reduction potential of ‘generous constraints’ M Harris, T Rhodes International Journal of Drug Policy 24 (6), e43-e50, 2013 | 123 | 2013 |
Breaking worse: the emergence of krokodil and excessive injuries among people who inject drugs in Eurasia JPC Grund, A Latypov, M Harris International Journal of Drug Policy 24 (4), 265-274, 2013 | 123 | 2013 |
Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs M Harris, T Rhodes Addiction 107 (6), 1090-1096, 2012 | 101 | 2012 |
Injecting, infection, illness: abjection and hepatitis C stigma M Harris Body & Society 15 (4), 33-51, 2009 | 88 | 2009 |
Taming systems to create enabling environments for HCV treatment: negotiating trust in the drug and alcohol setting M Harris, T Rhodes, A Martin Social science & medicine 83, 19-26, 2013 | 85 | 2013 |
“Three in the room” embodiment, disclosure, and vulnerability in qualitative research M Harris Qualitative Health Research 25 (12), 1689-1699, 2015 | 83 | 2015 |
Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment T Rhodes, M Harris, A Martin Sociology of health & illness 35 (7), 1023-1044, 2013 | 82 | 2013 |
Troubling biographical disruption: narratives of unconcern about hepatitis C diagnosis M Harris Sociology of health & illness 31 (7), 1028-1042, 2009 | 79 | 2009 |
Normalised pain and severe health care delay among people who inject drugs in London: Adapting cultural safety principles to promote care M Harris Social Science & Medicine 260, 113183, 2020 | 76 | 2020 |
Fentanyl self-testing outside supervised injection settings to prevent opioid overdose: Do we know enough to promote it? CR McGowan, M Harris, L Platt, V Hope, T Rhodes International Journal of Drug Policy 58, 31-36, 2018 | 76 | 2018 |
Opiate injection–associated skin, soft tissue, and vascular infections, England, UK, 1997–2016 D Lewer, M Harris, V Hope Emerging infectious diseases 23 (8), 1400, 2017 | 74 | 2017 |
Fire in the vein: heroin acidity and its proximal effect on users’ health D Ciccarone, M Harris International Journal of Drug Policy 26 (11), 1103-1110, 2015 | 74 | 2015 |
Human rights and access to hepatitis C treatment for people who inject drugs D Wolfe, N Luhmann, M Harris, A Momenghalibaf, E Albers, J Byrne, ... International Journal of Drug Policy 26 (11), 1072-1080, 2015 | 73 | 2015 |
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy J Grebely, J Bruneau, P Bruggmann, M Harris, M Hickman, T Rhodes, ... International Journal of Drug Policy 47, 26-33, 2017 | 69 | 2017 |
“I can’t do this, it’s too much”: building social inclusion in cancer diagnosis and treatment experiences of Aboriginal people, their carers and health workers C Treloar, R Gray, L Brener, C Jackson, V Saunders, P Johnson, M Harris, ... International journal of public health 59, 373-379, 2014 | 60 | 2014 |
Finding the undiagnosed: a qualitative exploration of hepatitis C diagnosis delay in the United Kingdom M Harris, E Ward, C Gore Journal of viral hepatitis 23 (6), 479-486, 2016 | 55 | 2016 |
Health literacy in relation to cancer: addressing the silence about and absence of cancer discussion among a boriginal people, communities and health services C Treloar, R Gray, L Brener, C Jackson, V Saunders, P Johnson, M Harris, ... Health & social care in the community 21 (6), 655-664, 2013 | 54 | 2013 |
LIVING WITH HEPATITIS C: THE MEDICAL ENCOUNTER. M Harris New Zealand Sociology 20 (1), 2005 | 51 | 2005 |